Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Combinatorial Chemistry|September 10, 2002
Standardization protocols and optimized precursor sets for the efficient application of automated parallel synthesis to lead optimization: a Mitsunobu exampleRobert G Gentles, Dariusz Wodka, David C Park, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2Anil Vasudevan, Dariusz Wodka, Mary K Verzal, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 3Andrew J Souers, Dariusz Wodka, Ju Gao, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1Andrew J Souers, Dariusz Wodka, Ju Gao, et al.Journal of Medicinal Chemistry|March 4, 2005
Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesityAndrew J Souers, Ju Gao, Michael Brune, et al.Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesityAndrew J Souers, Ju Gao, Dariusz Wodka, et al.Journal of Medicinal Chemistry|October 17, 2017
Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein KinasePing Lan, F Anthony Romero, Dariusz Wodka, et al.Bioorganic & Medicinal Chemistry Letters|January 20, 2007
An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonistsRajesh R Iyengar, John K Lynch, Mathew M Mulhern, et al.Journal of Medicinal Chemistry|March 31, 2006
Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonistsPhilip R Kym, Andrew J Souers, Thomas J Campbell, et al.Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Identification of diamino chromone-2-carboxamides as MCHr1 antagonists with minimal hERG channel activityAndrew S Judd, Andrew J Souers, Dariusz Wodka, et al.Pageof 2